← Back to Clinical Trials
Recruiting NCT05940831

NCT05940831 Mobile Health Intervention (Support-moms) in Antenatal Care to Improve Maternal Health in Uganda

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05940831
Status Recruiting
Phase
Sponsor Mbarara University of Science and Technology
Condition Maternal Health
Study Type INTERVENTIONAL
Enrollment 1,680 participants
Start Date 2024-05-01
Primary Completion 2028-02-29

Eligibility & Interventions

Sex All sexes
Min Age 10 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Support-MomsControl

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,680 participants in total. It began in 2024-05-01 with a primary completion date of 2028-02-29.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

High maternal mortality is a major public health problem in many settings. Because of low antenatal care (ANC) and skilled birth usage, Ugandan women and their children suffer from high maternal and perinatal mortality. The investigators developed a promising intervention (Support-Moms app) that shares targeted health information, and engages social support networks through scheduled reminders to help support pregnant women to utilize maternity services in rural Uganda. The investigators now propose to test and implement the Support-Moms intervention and hypothesize that Support-Moms will be feasible and cost-effective in improving utilization of available maternity care services, and ultimately reduce maternal and perinatal mortality.

Eligibility Criteria

Inclusion Criteria: Individuals who: * are in the first trimester of pregnancy who have not yet presented for ANC * reside in the catchment area of a study HC * are emancipated minors and adults aged ≥ 18 years * report access to a cell phone with reception in their home * are able to identify at least two social supporters living within the study districts * are able to provide consent. * are from participants' existing social support network, with whom they have had stable, long-term relationships Exclusion Criteria: Participants will be excluded from the study if they: * do not own a cell phone for personal use with reported reliable reception * are unable to use SMS or unwilling to receive SMS notifications Potential social supporters will be excluded from the study if they: * are under 18 years of age * do not own a cell phone for personal use with reported reliable reception * are unable to use SMS or unwilling to receive SMS notifications * have not had stable, long-term relationships with the participants * are not aware that the study participant is pregnant

Contact & Investigator

Central Contact

Esther C. Atukunda, PhD

✉ eatukunda@must.ac.ug

📞 +256 782949832

Principal Investigator

Esther C. Atukunda, PhD

PRINCIPAL INVESTIGATOR

Mbarara University of Science and Technology

Frequently Asked Questions

Who can join the NCT05940831 clinical trial?

This trial is open to participants of all sexes, aged 10 Years or older, up to 65 Years, studying Maternal Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05940831 currently recruiting?

Yes, NCT05940831 is actively recruiting participants. Contact the research team at eatukunda@must.ac.ug for enrollment information.

Where is the NCT05940831 trial being conducted?

This trial is being conducted at Mbarara, Uganda, Mbarara, Uganda.

Who is sponsoring the NCT05940831 clinical trial?

NCT05940831 is sponsored by Mbarara University of Science and Technology. The principal investigator is Esther C. Atukunda, PhD at Mbarara University of Science and Technology. The trial plans to enroll 1,680 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology